Pharmathen Eyes US Growth As Owner Announces Sale
BC Partners Divests Pharmathen To Swiss-Based Partners Group
With plans to drive continuous innovation in drug administration technology and further implement state-of-the-art production capabilities, Swiss-based private equity Partners Group has announced a deal to acquire long-acting injectables specialist Pharmathen.
